BioWorld-Insight-2010-08-16
If NIH Challenges Genzyme's Patents, Does Anyone Care?
M&A Not Meeting Gangbuster Expectations So Far This Year
At the J.P. Morgan healthcare conference in January, everyone was predicting that 2010 would be a gangbusters year for biotech mergers and acquisitions.

